๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Drug absorption from in situ rat small intestine during metoclopramide administration

โœ Scribed by Vesa M. K. Venho


Publisher
John Wiley and Sons
Year
1979
Tongue
English
Weight
197 KB
Volume
68
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

โœฆ Synopsis


The effect of metoclopramide on the absorption of drugs in solution in the small intestinal lumen of rats in situ was studied. Metoclopramide in doses up to 50 mg/kg sc did not significantly modify the disappearance of isoniazid and quinidine from the small intestinal lumen. At the end of the absorption experiments, quinidine in the whole blood of the experimental animals was increased after metoclopramide. The blood level did not correlate to the drug disappearance from the intestinal lumen. The results probably differ from those obtained when drugs are given orally to subjects treated with metoclopramide.


๐Ÿ“œ SIMILAR VOLUMES


Prediction of in vivo intestinal absorpt
โœ Manthena V.S. Varma; Ramesh Panchagnula ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 180 KB ๐Ÿ‘ 1 views

The purpose of this study is to determine the functional role of P-glycoprotein (P-gp) in intestinal absorption of drugs and to quantitatively predict the in vivo absorption enhancement on P-gp inhibition. In situ single-pass rat ileum permeability and aqueous solubility were measured for a set of 1

Absorption barriers in the rat intestina
โœ Daniel R. Mudra; Ronald T. Borchardt ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 457 KB ๐Ÿ‘ 1 views

Modulation of intestinal drug absorption barriers can have a profound impact on the bioavailability of orally administered compounds. With its commonality of use as an absorption model, it is valuable to assess the role of such barriers in the rat intestinal mucosa. In the present study, atenolol an